Durham-based Aerie Pharma sees positive study results for eye pressure drug
Aerie Pharmaceuticals continues expansion in Durham as it sees positive study results for its lead drug.
Read MorePosted by WRAL News | Aug 20, 2018
Aerie Pharmaceuticals continues expansion in Durham as it sees positive study results for its lead drug.
Read MorePosted by WRAL News | Dec 29, 2017
Aerie Pharmaceuticals, a California-based Duke University spinoff that has research and development operations in the Triangle, has received US Food and Drug administration approval for its glaucoma drug delivered once a day via eyedrops.
Read More